Product Description
Description: Torque’s Torcort M 40 Tablets contain methylprednisolone which is a glucocorticoid. It exhibits anti-inflammatory and immunosuppressive properties.
Pharmaceutical Dosage Form: Dry Injection
Route of Administration: Intramuscular/Intravenous
Composition: Each vial contains:
Methylprednisolone Sodium Succinate USP eq. to Methylprednisolone 40 mg
Mechanism of Action: Methylprednisolone is used for its anti-inflammatory effects in disorders of many organ systems. It acts in various ways to decrease the inflammatory cycle including: dampening the inflammatory cytokine cascade, inhibiting the activation of T cells, decreasing the extravasation of immune cells into the central nervous system, facilitating the apoptosis of activated immune cells, and indirectly decreasing the cytotoxic effects of nitric oxide and tumor necrosis factor alpha.
Indications: Torque’s Torcort M 40 is indicated for severe allergic, dermatologic, endocrine, gastrointestinal, hematologic, neoplastic, nervous system, ophthalmic, renal, respiratory, rheumatic disorders unresponsive to conventional treatments, localized inflammatory or hypertrophic lesions (e.g., alopecia areata, keloids, psoriatic plaques, ganglia), acute and chronic joint or soft tissue inflammatory conditions (e.g. arthritis, bursitis, tenosynovitis).
Dosage: As directed by the physician.
Storage: Store protected from light & moisture, at a temperature not exceeding 25°C.
Presentation: 40mg vial
Side effects:
Abdominal distention
Muscle weakness
Loss of muscle mass
Osteoporosis
Hypertension
Fluid & Electrolyte Disturbance
Contraindications: Torque’s Torcort M 40 is contraindicated in patients with a known allergy to constituents or excipients, and in premature infants.
Drug Interactions: Torque’s Torcort M 40 can cause drug interaction with following drugs:
Oral Anticoagulants
Cyclosporine
Phenobarbital
Phenytoin
Rifampin
Aspirin
Ketoconazole
CYP3A4 Inhibitors
CYP3A4 Inducers
Carbamazepine
Neuromuscular Blocking Agents
Antidiabetics
NSAID’s
